Expand TERN Menu
TERN MENU

TERN Latest Press Releases

-- April 27, 2026 --

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia Globe Newswire 8:05 AM

-- April 24, 2026 --

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc. Business Wire 6:45 AM

-- April 15, 2026 --

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders? PRNewswire 7:59 AM

-- April 10, 2026 --

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN Business Wire 3:37 PM

-- April 9, 2026 --

Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? PRNewswire 3:29 PM

-- April 7, 2026 --

Halper Sadeh LLC is Investigating Whether EWCZ, MKC, TERN are Obtaining Fair Deals for their Shareholders Globe Newswire 9:57 AM
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. Business Wire 9:00 AM
Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders Globe Newswire 6:52 AM

-- April 2, 2026 --

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) Globe Newswire 4:05 PM

-- March 26, 2026 --

Are TERN, CRBG, EQH Obtaining Fair Deals for their Shareholders? PRNewswire 10:50 AM

-- March 25, 2026 --

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN Business Wire 9:59 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Terns Pharmaceuticals, Inc. (NASDAQ: TERN) PRNewswire 1:30 PM
Shareholder Alert: The Ademi Firm investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders PRNewswire 10:00 AM
TERN Stock Alert: Halper Sadeh LLC is Investigating Whether Terns Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders Business Wire 7:53 AM
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) Globe Newswire 6:48 AM
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) Business Wire 6:45 AM

-- February 25, 2026 --

Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences Globe Newswire 4:05 PM

-- February 2, 2026 --

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) Globe Newswire 4:05 PM

-- January 7, 2026 --

Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 4:05 PM

-- January 2, 2026 --

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) Globe Newswire 4:05 PM

-- December 11, 2025 --

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:05 PM

-- December 9, 2025 --

Terns Announces Pricing of Upsized $650 Million Public Offering Globe Newswire 11:30 PM
Terns Announces Proposed Public Offering Globe Newswire 6:12 AM

-- December 8, 2025 --

Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701's Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting Globe Newswire 2:45 PM
Market Data Delayed 15 Minutes